Sosei to repurchase all ¥150 million 0.25% convertibles due 2026

By Mary-Katherine Stinson

Lexington, Ky., March 14 – Sosei Group Corp. will repurchase all its outstanding ¥150 million of 0.25% convertible bonds due 2026 (ISIN: XS2363140810), according to a notice.

The convertibles will be repurchased on March 18 and subsequently will be canceled and delisted from the Singapore Exchange.

The original issue size was ¥30 billion.

The biopharmaceutical group is based in Tokyo and has research facilities in Cambridge, U.K. Its corporate brand and trademark is Sosei Heptares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.